arrow
A

Annabella Di Mauro

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
H指数:17
被引数:842

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Domain-Adaptive Transfer Learning for HPV Lesion Classification in Whole Slide Images: A Patient-Level Pipeline Across the Cytology–Histology Continuum

基于域自适应迁移学习的全切片图像HPV病变分类:跨越细胞学-组织学连续体的患者级流程

2026-06-050
OA
Genomic profiling of a DICER1-wildtype thyroblastoma reveals AGK-BRAF fusion; EIF1AX duplication; and TERT promoter mutations: integrated genomic and pathway analysis

DICER1野生型甲状腺母细胞瘤的基因组分析揭示AGK-BRAF融合、EIF1AX复制和TERT启动子突变:整合基因组学和通路分析

2026-04-220
OAAI
Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study

卡博替尼和替莫唑胺在晚期进展性神经内分泌肿瘤患者中的应用:一项II期研究

2026-04-100
OAAI
Modern Pathology-Driven Strategies in Neoadjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma: From Residual Tumor Quantification to Spatial and AI-Based Biomarkers

《头颈鳞状细胞癌新辅助免疫治疗中的现代病理驱动策略:从残余肿瘤量化到空间及基于AI的生物标志物》

Cancers
IF4.4
2026-04-030
OAAI
Clinical and genetic drivers of oligo-metastatic disease in colon cancer

结肠癌寡转移性疾病的临床和遗传驱动因素

2025-02-010
OAAI
High tumor mutational burden assessed through next-generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patients (vol 22, 1107, 2024)
2025-01-080
OAAI
High tumor mutational burden assessed through next-generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patients

通过下一代测序评估的高肿瘤突变负荷可预测微卫星稳定的转移性结肠癌患者的良好生存率

2024-12-051
OAAI
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer
2024-07-240
OAAI
Immune cell infiltration and inflammatory landscape in primary brain tumours

原发性脑肿瘤中的免疫细胞浸润和炎症景观

2024-05-300
OAAI
Machine learning and radiomics analysis by computed tomography in colorectal liver metastases patients for RAS mutational status prediction

通过计算机断层扫描对结直肠癌肝转移患者进行机器学习和放射组学分析,以预测RAS突变状态

2024-05-184
PRE
A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial

替莫唑胺作为晚期神经内分泌癌的二线治疗的新时间表 (TENEC试验): 一项多中心,开放标签,单臂,II期临床试验

2024-05-011
OAAI
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy (vol 15, 68, 2024)
2024-01-181
OAAI
Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

来自胃肠道的寡转移肿瘤: 临床和分子驱动因素的鉴定: 预测研究

2023-10-190
OAAI